Skip to content

Analysis of the impact of clinical pharmacist participation in anti-Infection consultations on the efficacy and rationality of antimicrobial use

Analysis of the impact of clinical pharmacist participation in anti-Infection consultations on the efficacy and rationality of antimicrobial use

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117544
Enrollment
Unknown
Registered
2026-01-26
Start date
2026-01-27
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various infections

Interventions

Clinical Pharmacist Consultation Group:None
Clinical Pharmacist Non-Consultation Group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Exposure group: (1) Patients with clinical pharmacist consultation; (2) Patients whose consultation purpose is related to antimicrobial use; (3) Patients for whom the clinical pharmacist provides recommendations on antimicrobial dosing regimens; (4) Patients with complete clinical data; 2. Control group: (1) Patients without clinical pharmacist consultation; (2) Patients receiving antimicrobial therapy during the same period; (3) Patients with complete clinical data;

Exclusion criteria

Exclusion criteria: 1.Clinical data is incomplete; 2.Patients hospitalized for less than 24 hours; 3.Patients discharged or deceased within 48 hours after consultation; 4.The purpose of the consultation is clearly for patients applying for higher-level antibiotics or combination therapy.

Design outcomes

Primary

MeasureTime frame
Effectiveness of treatment for infectious diseases;Rational use rate of antimicrobial drugs;

Secondary

MeasureTime frame
Incidence of adverse drug reactions (ADR);In-hospital infection-related mortality;Antibiotic Costs (Yuan);Adoption rate of consultation opinions;Cumulative DDD of antimicrobial drugs;

Countries

China

Contacts

Public ContactLi Jie

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

157512890@qq.com+86 27 84392371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026